The global over-the-counter (OTC) pain medication market is poised for steady growth, with its market size expected to attain ...

Any lingering hope that Pfizer may finally get a regulatory approval ... after the EMA's human medicines committee rejected the drug. A positive recommendation was already looking like a long ...

A mother says years of painful headaches and speech issues from brain tumors were caused by prolonged use of a Pfizer birth ...

In 2023, the then 49-year-old went to her physician with painful headaches, blurring vision, pain and swelling of her eyes ...

Pfizer acquired Global Blood Therapeutics ... in addition to other debilitating symptoms caused by the medication including pain and swelling. While on the drug, the plaintiff suffered a stroke ...

Travis Kelce is one of the most well-known faces in professional football, helping him to support important causes.

In October 2024, Topas Therapeutics announced positive topline results from its Phase IIa trial of TPM502, in patients with celiac disease. The study data serves as the first clinical proof of concept ...

Key drugs in shortage include ADHD medications, pain treatments ... Fresenius Kabi, Hikma, Pfizer, and Piramal Critical Care. Conversely, Fresenius Kabi, Hikma, and Pfizer continue to face ...

Rather than bribing and wheedling physicians to pretty-please-prescribe-our-drug, websites allow companies to deal drugs ...

Recent peer-reviewed study supports what patients shared with their own voices: Automated red blood cell exchange improves the l ...

A non-opioid drug for pain developed by UK biotech Levicept ... LEVI-04 was originally discovered at Pfizer's R&D facility in Sandwich, Kent, by Levicept founder Simon Westbrook, and was spun ...